Pre-Operative Window of Adjuvant Endocrine Therapy to Inform RT Decisions in Older Women With Early-Stage Breast Cancer

NCT04272801 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Female

Interventions

DRUG: tamoxifen, letrozole, anastrozole, or exemestane
BEHAVIORAL: Patient reported outcomes

Sponsor

Shayna Showalter, MD

Collaborators

[object Object]